BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 29630912)

  • 21. Reflectance confocal microscopy for diagnosis of mammary and extramammary Paget's disease.
    Guitera P; Scolyer RA; Gill M; Akita H; Arima M; Yokoyama Y; Matsunaga K; Longo C; Bassoli S; Bencini PL; Giannotti R; Pellacani G; Alessi-Fox C; Dalrymple C
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):e24-9. PubMed ID: 22211938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequent
    Takeichi T; Okuno Y; Matsumoto T; Tsunoda N; Suzuki K; Tanahashi K; Kono M; Kikumori T; Muro Y; Akiyama M
    Cancers (Basel); 2020 Mar; 12(4):. PubMed ID: 32235312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytokeratin 7 staining in mammary and extramammary Paget's disease.
    Smith KJ; Tuur S; Corvette D; Lupton GP; Skelton HG
    Mod Pathol; 1997 Nov; 10(11):1069-74. PubMed ID: 9388055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mammary and extramammary Paget's disease: an immunohistochemical study of 83 cases.
    Liegl B; Leibl S; Gogg-Kamerer M; Tessaro B; Horn LC; Moinfar F
    Histopathology; 2007 Mar; 50(4):439-47. PubMed ID: 17448019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of ras p21 in mammary and extramammary Paget's disease.
    Mori O; Hachisuka H; Nakano S; Sasai Y; Shiku H
    Arch Pathol Lab Med; 1990 Aug; 114(8):858-61. PubMed ID: 1695839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human epidermal growth factor receptor 2 expression in extramammary Paget's disease and mammary Paget's disease.
    Jeong SH; Hyeong JH; Park EJ; Kim KJ; Kim KH
    Australas J Dermatol; 2022 Feb; 63(1):115-118. PubMed ID: 34964488
    [No Abstract]   [Full Text] [Related]  

  • 27. The role of HER-2/neu oncogene and vimentin filaments in the production of the Paget's phenotype.
    Hanna W; Alowami S; Malik A
    Breast J; 2003; 9(6):485-90. PubMed ID: 14616943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemistry of mammary Paget's disease. Cytokeratin 7, GATA3, and HER2 are sensitive markers.
    Arain SA; Arafah M; Said Raddaoui EM; Tulba A; Alkhawaja FH; Al Shedoukhy A
    Saudi Med J; 2020 Mar; 41(3):232-237. PubMed ID: 32114594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Expression status of HER2 in mammary and extramammary Paget's disease].
    Meng H; Zheng XY; Zhang L; Li WC
    Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):255-6. PubMed ID: 21616001
    [No Abstract]   [Full Text] [Related]  

  • 30. Different panels of markers should be used to predict mammary Paget's disease associated with in situ or invasive ductal carcinoma of the breast.
    Lester T; Wang J; Bourne P; Yang Q; Fu L; Tang P
    Ann Clin Lab Sci; 2009; 39(1):17-24. PubMed ID: 19201736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinguishing tumour cells of mammary from extramammary Paget's disease using antibodies to two different glycoproteins from human milk-fat-globule membrane.
    Imam A; Yoshida SO; Taylor CR
    Br J Cancer; 1988 Sep; 58(3):373-8. PubMed ID: 2846025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of differentiation antigens in mammary and extramammary Paget's disease.
    Kariniemi AL; Forsman L; Wahlström T; Vesterinen E; Andersson L
    Br J Dermatol; 1984 Feb; 110(2):203-10. PubMed ID: 6320859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparative immunohistochemical study of mammary and extramammary Paget's disease and superficial spreading melanoma, with particular emphasis on melanocytic markers.
    Ramachandra S; Gillett CE; Millis RR
    Virchows Arch; 1996 Dec; 429(6):371-6. PubMed ID: 8982382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Penoscrotal Paget's disease.
    Dauendorffer JN; Herms F; Baroudjian B; Basset-Seguin N; Cavelier-Balloy B; Fouéré S; Bagot M; Lebbé C
    Ann Dermatol Venereol; 2021 Jun; 148(2):71-76. PubMed ID: 33461789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HER2 oncogene amplification in extramammary Paget's disease.
    Tanskanen M; Jahkola T; Asko-Seljavaara S; Jalkanen J; Isola J
    Histopathology; 2003 Jun; 42(6):575-9. PubMed ID: 12786893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [An immunohistochemical analysis of extramammary Paget's disease compared with mammary Paget's disease].
    Hasebe T; Yamamichi N; Konishi F; Mukawa A
    Gan No Rinsho; 1988 Feb; 34(2):159-66. PubMed ID: 2831411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidermal cell cultures from involved skin of patients with mammary and extramammary Paget's disease.
    Mori O; Karashima T; Matsuo K; Hashimoto T
    Kurume Med J; 1997; 44(3):165-9. PubMed ID: 9339646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Not All Cases of Mammary Paget's Disease are Cytokeratin-7 Positive: A Challenging Diagnosis!
    Anja K; Hélène D; Pascal VE; Liliane M; Mieke VB
    Int J Surg Pathol; 2021 Sep; 29(6):631-634. PubMed ID: 33750236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular subtyping of mammary Paget's disease using immunohistochemistry.
    Arafah M; Arain SA; Raddaoui EMS; Tulba A; Alkhawaja FH; Al Shedoukhy A
    Saudi Med J; 2019 May; 40(5):440-446. PubMed ID: 31056619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathological Relevance and Prognostic Value of Androgen Receptor in Mammary Paget's Disease with Underlying Invasive Ductal Carcinoma.
    Zhang M; Meng X; Guo C; Liu J; Xing Z; Wang X; Wang X
    Oncol Res Treat; 2020; 43(7-8):346-353. PubMed ID: 32645702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.